Surgical hemostats market seen reaching $5.41 billion by 2030

The surgical hemostats market is projected to grow from $3.93 billion in 2025 to $5.41 billion by 2030, driven by rising surgical volumes, trauma cases and adoption of advanced hemostatic products. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Surgical hemostats help surgeons control bleeding, keep the surgical field clear and improve patient safety. - Market growth points to more demand for products used in routine, emergency and minimally invasive procedures. - Rising trauma cases and more surgeries are increasing the need for blood-loss management tools.

What happened: - The Business Research Company projected the surgical hemostats market will rise from $3.93 billion in 2025 to $4.2 billion in 2026. - The report expects the market to reach $5.41 billion by 2030. - The forecast implies a 6.9% CAGR from 2025 to 2026 and a 6.5% CAGR through 2030. - The company published the outlook on Aug. 31, 2026. - The report includes a free sample and a full market report.

The details: - Surgical hemostats are tools or agents used during operations to clamp blood vessels or promote clot formation. - The products are used to reduce blood loss and support visibility during surgery. - Growth over the historical period was driven by more surgical procedures, stronger demand for blood-loss management, advances in surgical instruments, expanded hospital infrastructure and greater awareness of patient safety protocols. - Future growth drivers include hemostatic product innovation, broader use of robotic-assisted surgeries, growth in outpatient surgical centers, AI integration in healthcare and rising demand for biodegradable surgical hemostats. - The report highlights trends in minimally invasive surgery, advanced hemostatic materials, point-of-care hemostasis monitoring, AI-supported surgical planning and sustainable surgical supplies. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - Trauma care is emerging as a major demand driver because bleeding control is critical in urgent operations. - The report points to a market shifting toward smarter, less invasive and more sustainable surgical tools. - Faster growth in Asia-Pacific suggests healthcare buildout and surgical volume gains are becoming more important than mature-market expansion alone. - The Wisconsin Department of Health Services reported a 3% increase in traumatic injuries caused by assault in 2023, rising from 1,544 to 1,584 cases.

What's next: - The market is expected to keep expanding through 2030 as surgical demand rises and hospitals adopt newer hemostatic technologies. - The report says 2026 editions now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel dashboards, market hotspot infographics and updated technology and trend analysis. - The Business Research Company promoted direct contact options for its research and sales teams, including email and regional phone numbers.

The bottom line: - Surgical hemostats are moving from a steady-growth niche into a broader medtech category tied to surgery volume, trauma response and product innovation.